Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 55.45 | N/A |
| PEG Ratio (TTM) | 18.85 | N/A |
| P/S Ratio (TTM) | 3.38 | N/A |
| P/B Ratio (TTM) | 0.96 | N/A |
| P/FCF Ratio (TTM) | 22.61 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.26% | N/A |
| ROE (TTM) | 1.73% | N/A |
| Net Profit Margin (TTM) | 5.61% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -23.67% | N/A | N/A |
| Revenue | 23.51% | N/A | N/A |
| Net Income | -24.91% | N/A | N/A |
| Cash Flow | 11.56% | N/A | N/A |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 137.45 | N/A |
| Quick Ratio (TTM) | 137.45 | N/A |
| D/E Ratio (TTM) | 0.16 | N/A |
| Interest Coverage (TTM) | 0.31 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.46 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |